e3pzwrup | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/e3pzwrup_hasAnnotation_C0036341> <https://research.tib.eu/covid-19/entity/e3pzwrup_hasAnnotation_C1825598>
?:creator	<https://research.tib.eu/covid-19/entity/Kott%2C_A.%3B_Daniel%2C_D.G.>
?:doi	<https://research.tib.eu/covid-19/entity/10.1016/j.euroneuro.2020.09.372>
?:doi	10.1016/j.euroneuro.2020.09.372
?:journal	Eur_Neuropsychopharmacol
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/56c595145412d076f921a331e40733fd518ff647.json
?:pmc_json_files	document_parses/pmc_json/PMC7670888.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7670888>
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/56c595145412d076f921a331e40733fd518ff647>
?:source	Elsevier; PMC
?:title	P.508 COVID-19 impact on entry symptom severity in schizophrenia clinical trials – preliminary data
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-17

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/e3pzwrup>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/e3pzwrup>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all